Text Size
13 studies found for:    teriflunomide

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed
Has Results 		Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide);   Drug: Glatiramer Acetate (GA)
2 Completed
Has Results 		Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for Teriflunomide);   Drug: Interferon-β
3 Completed
Has Results 		Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide)
4 Completed Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (placebo for teriflunomide)
5 Completed
Has Results 		Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide);   Drug: Interferon-β [IFN-β];   Drug: Glatiramer Acetate [GA]
6 Completed
Has Results 		Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide
Condition: Multiple Sclerosis
Interventions: Drug: teriflunomide;   Drug: Interferon-β-1;   Biological: Influenza vaccine
7 Completed Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta
Condition: Multiple Sclerosis Relapse
Interventions: Drug: Teriflunomide (HMR1726);   Drug: Matching placebo
8 Active, not recruiting
Has Results 		A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: interferon β-1a;   Drug: teriflunomide
9 Active, not recruiting Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide (HMR1726);   Drug: Placebo
10 Completed Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal Impairment
Condition: Renal Impairment
Interventions: Drug: Teriflunomide HMR1726;   Drug: Cholestyramine
11 Active, not recruiting An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide (HMR1726);   Drug: Placebo
12 Active, not recruiting Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses
Condition: Multiple Sclerosis
Intervention: Drug: teriflunomide (HMR1726)
13 Active, not recruiting Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: teriflunomide (HMR1726)
To Top

† Indicates status has not been verified in more than two years